Answers are grounded in this paper and cite their sources.
In vitro study demonstrates distinct pathways of δ-aminolevulinic acid synthetase induction in avian hepatocytes, highlighting heme-mediated feedback repression relevant to acute porphyria.
The regulation of heme biosynthesis has been studied in cultured avian hepatocytes utilizing a specific and sensitive assay for the rate-limiting enzyme in the pathway, δ-aminolevulinic acid synthetase. This enzyme appears to be induced by 2-allyl-2-isopropylacetamide, a drug known to produce experimental porphyria, and by inhibitors of heme synthesis such as lead acetate. However, 2-allyl-2-isopropylacetamide and lead acetate appear to induce δ-aminolevulinic acid synthetase by different mechanisms since inhibitors of protein synthesis at the transcriptional level block induction by 2-allyl-2-isopropylacetamide but not block induction by lead acetate. Furthermore, induction by the two chemicals is synergistic. Addition of the end product of the pathway, heme, and the heme precursor, δ-aminolevulinic acid, prevents induction by 2-allyl-2-isopropylacetamide and lead acetate. These data further support the role of heme as the natural repressor of δ-aminolevulinic acid synthetase. Experiments with inhibitors of protein synthesis are consistent with a translational site for heme repression. A mechanism whereby drugs may induce δ-aminolevulinic acid synthetase by interfering with heme synthesis is demonstrated. The relevance of these observations to the biochemical aberration characterizing the human genetic disease, intermittent acute porphyria, is discussed.
No takes yet. Share an insight, caveat, or question.
Strand et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: